Information:
Error:
ID
16501
Description
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00212615
Link
https://clinicaltrials.gov/show/NCT00212615
Keywords
Versions (1)
- 7/20/16 7/20/16 -
Uploaded on
July 20, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility C04.588.274.476.411.307 NCT00212615
Eligibility C04.588.274.476.411.307 NCT00212615
- StudyEvent: Eligibility
Similar models
Eligibility C04.588.274.476.411.307 NCT00212615
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Adenocarcinoma of colon | Adenocarcinoma of rectum
Item
histological proven adenocarcinoma of the colon or rectum
boolean
C0338106 (UMLS CUI [1])
C0149978 (UMLS CUI [2])
C0149978 (UMLS CUI [2])
Measurable Disease
Item
measurable or non-measurable disease
boolean
C1513041 (UMLS CUI [1])
performance status
Item
performance status 0-2
boolean
C1518965 (UMLS CUI [1])
Renal function | Liver function
Item
adequate renal and hepatic functions
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232741 (UMLS CUI [2])
Adjuvant Chemotherapy Ended
Item
adjuvant chemotherapy must have ended 180 days before inclusion
boolean
C0085533 (UMLS CUI [1,1])
C1272693 (UMLS CUI [1,2])
C1272693 (UMLS CUI [1,2])
Informed consent
Item
written informed consent prior to randomization
boolean
C0021430 (UMLS CUI [1])
Eloxatin | Xeloda
Item
prior treatment with eloxatin or xeloda
boolean
C1135117 (UMLS CUI [1])
C0724419 (UMLS CUI [2])
C0724419 (UMLS CUI [2])
Peripheral Neuropathy
Item
peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
CNS metastases Evidence of
Item
evidence of cns metastasis
boolean
C0686377 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,2])
Illness Serious | Other medical condition | Medical contraindication Fluorouracil | Angina Pectoris | Myocardial Infarction
Item
other serious illness or medical conditions (including contraindication to 5 fu e.g.: angor, myocardial infarction within 6 months)
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C0016360 (UMLS CUI [3,2])
C0002962 (UMLS CUI [4])
C0027051 (UMLS CUI [5])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C0016360 (UMLS CUI [3,2])
C0002962 (UMLS CUI [4])
C0027051 (UMLS CUI [5])
Malignant Neoplasms | Skin carcinoma curative treatment
Item
past history of malignant neoplasm within the past five years, except curatively treated non melanoma skin cancer
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0699893 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
Investigational New Drugs
Item
administration of any other experimental drug under investigation within 2 weeks before randomisation
boolean
C0013230 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Fertility Contraceptives
Item
fertile patients must use adequate contraceptives
boolean
C0015895 (UMLS CUI [1,1])
C0009871 (UMLS CUI [1,2])
C0009871 (UMLS CUI [1,2])